Agion Antimicrobial Efficacy Against Coronavirusis Testedand Published

Feb 26, 2020

Leave a message

One of additives used in fabrics produced by our company for many years. In this new coronavirus(COVID-19) test,shows good results.

The technology is deployed in the EU, Canada and United States in FDA cleared N95 respirator

February 10, 2020

The novel coronavirus (nCoV) outbreak in China has prompted several inquiries to Sciessent regarding 

the ability of Agion Antimicrobial to inactivate viruses. This white paper summarizes some university 

and government research previously completed on the antiviral properties of Agion.

InitialResearch

The first half of the 2000’s was marked by viral outbreaks that 

included H5N1 avian influenza, norovirus on cruise ships and the 

SARS coronavirus. Sciessent(formerly Agion Technologies)engaged 

with university researchers, industry partners and government

organizations to investigate the ability of Agion to inactivate viruses. 

At the time the Chinese Center for Disease Control was looking for 

approaches to control the coronavirus and evaluated the Agion 

powder for efficacy. Around the same time Sciessent began working 

with Prof. Charles Gerba at the University of Arizonaandto evaluate 

antiviral properties of Agion. 

Test Results

Chinese CDC(2003)

•Complete inactivation of SARS coronavirus in 2hours

•VERO E6 cell substrate, using virus CPE method

University of Arizona(2004)

•90% reduction of human coronavirus 229E in 1 hour

•99% reduction of human coronavirus 229E in 2 hours

•99.999% reduction of human coronavirus 229E in 24 hours

•TCID50 technique, monitoring MRC-5 cell monolayers for cytopathic effects

A Note on Terminology

Viruses are not living 

organisms; they must enter 

a living cell to multiply. 

Therefore, antiviral agents 

are said to “inactivate” 

viruses, not “kill” them.

Chinese Academy of Agricultural Sciences(2006)

•99% reduction of H5N1 avian influenza in 10 minutes

•Klein-Defors suspension eradication test

Published Research

A portion of the above results were published by Professor Gerba and his team in the peer-reviewed 

scientific journal Food and Environmental Virology:

Assessment of the Antiviral Properties of Zeolites Containing Metal Ions, 

Food Environ Virol (2009) 1:37–41

Abstract

The antiviral properties of zeolite (sodium aluminosilicate) powders amended with metal 

ions were assessed using human coronavirus 229E, feline infectious peritonitis virus (FIPV), 

and feline calicivirus F-9. Zeolites containing silver and silver/copper caused significant 

reductions of coronavirus 229E after 1 h in suspension. The silver/copper combination 

yielded a >5.13-log10 reduction within 24 h. It was also the mosteffective (>3.18-log10) 

against FIPV after 4 h. Other formulations were ineffective against FIPV. On plastic coupons 

with incorporated silver/copper-zeolites, >1.7-log10 and >3.8-log10 reductions were 

achieved for coronavirus 229E and feline calicivirus within 24 h, respectively. Silver/copper 

zeolite reduced titers of all viruses tested, suggesting that it may be effective against 

related pathogens of interest [i.e., SARS coronavirus, other coronaviruses, human 

norovirus (calicivirus)]. Of note, it was effective against both enveloped and nonenveloped 

viruses. Metal-zeolites could therefore possibly be used in applications to reduce virus 

contamination of fomites and thus the spread of viral diseases.

Note: Springer Nature is making Coronavirus research free, including the above article.

Agion in Polyester Fiber

During this time Sciessent worked with Foss Manufacturing (now Foss Performance Materials) to 

develop a polyester fiber with Agion embedded into the fiber itself. The fiber, named Fosshield, was 

incorporated into N95 respirator media as an approach to limit contamination of the respirator by 

the wearer or those around them. Further antiviral efficacy testing was performed on the respirator 

media construction.

N95 Respirator Media Test Results

•99.98% reduction of coronavirus in 4 hours*

•99.6% reduction of adenovirus in 1 hour*

•99.999% reduction of haemophilus influenzae in 1 hour*

•99.8% reduction of feline calicivirus (norovirus surrogate) in 4 hours*

*Results based on testing of samples containing Agion Antimicrobial

Once proven, the media was manufactured by Nexera Medical into an N95 respirator, which 

underwent extensive testing and was submitted to the FDA in 2009. The Nexera Spectrashield 

surgical respirator was cleared by NIOSH and received a 510(k) from the Food and Drug 

Administration in 2011and has since been cleared in Canada and the European Union.

Approved claims for the European Union:

http://www.nexeramed.com/nfiles/news_110711_1.php

Approved claims for Canada:

http://www.nexeramed.com/cfiles/regulatory.php?region=CA

Application Options

Agion is a versatile material that can be mixedinto coatings,

compounded intoplastics, and applied to textilesusing several 

processes:

Topical–Fastest and most versatile

•Pad/Dry/Cure

•Exhaust

•Dip/Extract

•Yarn Package

Embedded

•

Filament or staple fiber spinning

•Melt blown nonwoven

•Spunbond nonwoven

Contacts

Sciessent: wayne@kmtextile.net

The Agion® Antimicrobial is presently registered by the United States Environmental Protection Agency as a preservative and bacteriostatic 

agent for use in treated articles under 40 CFR 152.25a. The information presented herein is not intended to support or endorse public health 

claims for treated articles. The Agion Antimicrobial is also used in medical devices under the Food and Drug Administration in the US; those 

medical device claims are based onsafety and efficacy testing and are limited to those approved by FDA. In the EU, the Agion Antimicrobial 

is used in medical devices under the Medical Device Directive: those medical device claims are based on safety and efficacy testing and are 

limited tothose approved by the designated Competent Authorities and/or Notified Bodies


Send Inquiry